Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
HIV-1 infection–induced apoptotic microparticles inhibit human DCs via CD44
Davor Frleta, … , Barton F. Haynes, Nina Bhardwaj
Davor Frleta, … , Barton F. Haynes, Nina Bhardwaj
Published November 19, 2012
Citation Information: J Clin Invest. 2012;122(12):4685-4697. https://doi.org/10.1172/JCI64439.
View: Text | PDF
Research Article AIDS/HIV

HIV-1 infection–induced apoptotic microparticles inhibit human DCs via CD44

  • Text
  • PDF
Abstract

Acute HIV-1 infection results in dysregulated immunity, which contributes to poor control of viral infection. DCs are key regulators of both adaptive and innate immune responses needed for controlling HIV-1, and we surmised that factors elicited during acute HIV-1 infection might impede DC function. We derived immature DCs from healthy donor peripheral blood monocytes and treated them with plasma from uninfected control donors and donors with acute HIV-1 infections. We found that the plasma from patients with HIV specifically inhibited DC function. This suppression was mediated by elevated apoptotic microparticles derived from dying cells during acute HIV-1 infection. Apoptotic microparticles bound to and inhibited DCs through the hyaluronate receptor CD44. These data suggest that targeting this CD44-mediated inhibition by apoptotic microparticles could be a novel strategy to potentiate DC activation of HIV-specific immunity.

Authors

Davor Frleta, Carolyn E. Ochoa, Holger B. Kramer, Shaukat Ali Khan, Andrea R. Stacey, Persephone Borrow, Benedikt M. Kessler, Barton F. Haynes, Nina Bhardwaj

×

Figure 6

Mechanisms of apoptotic MP-mediated DC inhibition.

Options: View larger image (or click on image) Download as PowerPoint
Mechanisms of apoptotic MP-mediated DC inhibition.
(A) DCs were pretreat...
(A) DCs were pretreated with 50 μM Rac1 inhibitor (EMD Chemicals) for 30 minutes and then treated with control MPs, apoptotic MPs, or no MPs. DCs were subsequently washed and poly I:C stimulated, and cytokine production was analyzed the following day. (B) DCs were pretreated with 50 μM Rac1 inhibitor for 30 minutes and then treated with of CFSE-labeled control or apoptotic MPs (green). After 3 hours, DCs were mounted, stained with LAMP-1 (red) and DAPI nuclear stain (blue), and analyzed by confocal microscopy (original magnification, ×63; inset, ×252). Arrows indicate individual cells shown in insets. (C) DCs were pretreated with 10 μM cytochalasin D (CCD; Sigma-Aldrich) for 30 minutes and then treated with control MPs, apoptotic MPs, or no MPs. DCs were subsequently washed and poly I:C stimulated, and cytokine production was analyzed the following day.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts